299 related articles for article (PubMed ID: 30702491)
21. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Benner A; Schrotz-King P; Brenner H
Mol Oncol; 2020 Jan; 14(1):8-21. PubMed ID: 31652396
[TBL] [Abstract][Full Text] [Related]
22. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
[TBL] [Abstract][Full Text] [Related]
23. A panel of microRNA signature in serum for colorectal cancer diagnosis.
Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
[TBL] [Abstract][Full Text] [Related]
24. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
[TBL] [Abstract][Full Text] [Related]
25. Identification of a circulating microRNA signature for colorectal cancer detection.
Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
[TBL] [Abstract][Full Text] [Related]
26. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
28. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
29. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
32. A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study.
Pardini B; Ferrero G; Tarallo S; Gallo G; Francavilla A; Licheri N; Trompetto M; Clerico G; Senore C; Peyre S; Vymetalkova V; Vodickova L; Liska V; Vycital O; Levy M; Macinga P; Hucl T; Budinska E; Vodicka P; Cordero F; Naccarati A
Gastroenterology; 2023 Sep; 165(3):582-599.e8. PubMed ID: 37263306
[TBL] [Abstract][Full Text] [Related]
33. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
34. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
35. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
[TBL] [Abstract][Full Text] [Related]
37. A three-plasma miRNA panel predicts the risk of colorectal cancer: a community-based nested case‒control study.
Liu J; Chen B; Yang M; Qian Y; Shen Q; Chen H; Dong Y; Wang L; Jiao J
Sci Rep; 2023 Mar; 13(1):4196. PubMed ID: 36918702
[TBL] [Abstract][Full Text] [Related]
38. Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma.
Ma X; Chen Y; Tang W; Bao H; Mo S; Liu R; Wu S; Bao H; Li Y; Zhang L; Wu X; Cai S; Shao Y; Liu F; Peng J
J Hematol Oncol; 2021 Oct; 14(1):175. PubMed ID: 34702327
[TBL] [Abstract][Full Text] [Related]
39. Serum netrin-1 as a biomarker for colorectal cancer detection.
Li B; Shen K; Zhang J; Jiang Y; Yang T; Sun X; Ma X; Zhu J
Cancer Biomark; 2020; 28(3):391-396. PubMed ID: 32474463
[TBL] [Abstract][Full Text] [Related]
40. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
